FHIR Implementation Guide for NJSAMS
1.0.0 - release
1.0.0 - release
NJSAMS - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://fhir.njsams.rutgers.edu/NJSAMS-fhir/Questionnaire/OtherSubstanceDisordersQuestionnaire | Version: 1.0.0 | |||
| Draft as of 2022-08-31 | Computable Name: | |||
Criteria for Other (or Unknown) Substance Disorder
Generated Narrative: Questionnaire OtherSubstanceDisordersQuestionnaire
| LinkID | Text | Cardinality | Type | Description & Constraints |
|---|---|---|---|---|
  | Criteria for Other (or Unknown) Substance Disorder | Questionnaire | https://fhir.njsams.rutgers.edu/NJSAMS-fhir/Questionnaire/OtherSubstanceDisordersQuestionnaire#1.0.0 | |
  OthSubstDisSymptoms | null | 0..1 | group | |
  OthSubstDisSymptoms.801 | 801. The substance is often taken in larger amounts or over a longer period than was intended. | 0..1 | boolean | |
| OthSubstDisSymptoms.802 | 802. There is a persistent desire or unsuccessful efforts to cut down or control use of the substance. | 0..1 | boolean | |
| OthSubstDisSymptoms.803 | 803. A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover from it effect | 0..1 | boolean | |
| OthSubstDisSymptoms.804 | 804. Craving, or a strong desire or urge to use the substance. | 0..1 | boolean | |
| OthSubstDisSymptoms.805 | 805. Recurrent use of the substance resulting in a failure to fulfill major role obligations at work, school, or home | 0..1 | boolean | |
| OthSubstDisSymptoms.806 | 806. Continued use of the substance despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of its use | 0..1 | boolean | |
| OthSubstDisSymptoms.807 | 807. Important social, occupational, or recreational activities are given up or reduced because of the use of the substance. | 0..1 | boolean | |
| OthSubstDisSymptoms.808 | 808. Recurrent use of the substance in situations in which it is physically hazardous | 0..1 | boolean | |
| OthSubstDisSymptoms.809 | 809. Use of the substance is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance | 0..1 | boolean | |
| Tolerance | 810. Tolerance, as defined by either of the following: | 0..1 | group | |
| OthSubstDisSymptoms.Tolerance.811 | 811. A need for markedly increased amounts of the substance to achieve intoxication or the desired effect. | 0..1 | boolean | |
 OthSubstDisSymptoms.Tolerance.812 | 812. A markedly diminished effect with continued use of the same amount of the substance | 0..1 | boolean | |
| Withdrawal | 813. Withdrawal, as manifested by either of the following: | 0..1 | group | |
 OthSubstDisSymptoms.Withdrawal.814 | 814. The characteristic withdrawal syndrome for other [or unknown] substance [refer to Criteria A and B of the criteria sets for other[or unknown] substance withdrawal, pp 280-281.] | 0..1 | boolean | |
| OthSubstDisSymptoms.Withdrawal.815 | 815. The substance [or a closely related substance] is taken to relieve or avoid withdrawal symptoms | 0..1 | boolean | |
| OthSubstIntoxSymptoms | null | 0..1 | group | |
| OthSubstIntoxSymptoms.820 | 820. The development of a reversible substance-specific syndrome attributable to recent ingestion of [or exposure to] a substance that is not listed elsewhere or is unknown. | 0..1 | boolean | |
| OthSubstIntoxSymptoms.821 | 821. Clinically significant problematic behavioral or psychological changes that are attributable to the effect of the substance on the central nervous system [e.g., impaired motor coordination, psychomotor agitation or retardation, euphoria, anxiety,belligerence, mood liability, cognitive impairment, impaired judgement, social withdrawal] that developed during, or shortly after, use of the substance. | 0..1 | boolean | |
| OthSubstIntoxSymptoms.822 | 822. The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication with another substance. | 0..1 | boolean | |
| OthSubstWithdrawSymptoms | null | 0..1 | group | |
| OthSubstWithdrawSymptoms.830 | 830. Cessation of [or reduction in] use of a substance that has been heavy and prolonged | 0..1 | boolean | |
| OthSubstWithdrawSymptoms.831 | 831. The development of a substance-specific syndrome shortly after the cessation of [or reduction in] substance use. | 0..1 | boolean | |
| OthSubstWithdrawSymptoms.832 | 832. The substance-specific syndrome causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. | 0..1 | boolean | |
| OthSubstWithdrawSymptoms.833 | 833. The symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including wihtdrawal from another substance. | 0..1 | boolean | |
| OthSubstWithdrawSymptoms.834 | 834. The substance involved cannot be classified under any of the other substance categories [alcohol; caffeine; cannabis; opioids; sedatives, hypnotics, or anxiolytics; stimulants; or tobacco] or is unknown | 0..1 | boolean | |
| OthSubstUnspecifiedSymptoms | null | 0..1 | group | |
| OthSubstUnspecifiedSymptoms.840 | 840. This category applies to presentations in which symptoms characteristic of an other [or unknown] substance-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific other [or unknown] substance-related disorder or any of the disorders in the substance-related disorders diagnostic class. | 0..1 | boolean | |
| meetsOtherIntoxCriteria | null | 0..1 | group | |
| meetsOtherIntoxCriteria.1 | Meets Criteria for Other [or Unknown] Substance-Related Intoxication Diagnosis? | 0..1 | boolean | |
| unknownUseSubstName | null | 0..1 | group | |
 unknownUseSubstName.1 | Specify the Substance Name: | 0..1 | text | |
| unknownIntxSubstName | null | 0..1 | group | |
| unknownIntxSubstName.1 | Specify the Substance Name: | 0..1 | text | |
| unknownWithDrawSubstName | null | 0..1 | group | |
| unknownWithDrawSubstName.1 | Specify the Substance Name: | 0..1 | text | |
| unknownUnspecSubstName | null | 0..1 | group | |
| unknownUnspecSubstName.1 | Specify the Substance Name: | 0..1 | text | |
| Documentation for this format | ||||